Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
Clinical trial NCT04634539 · COMPLETED
Trial details
- NCT number
- NCT04634539
- Sponsor
- Jun Gong, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2023-07-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.